Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND: (IBB)

(Real Time Quote from BATS) As of May 27, 2015 10:04 AM ET

 Add to portfolio

$362.98 USD

362.98
111,088

+2.68 (0.74%)

Volume: 111,088

Zacks ETF Rank: 2 - Buy [?]   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 360.30
Open 362.51
Bid 363.52
Ask 363.68
Day Low-High 359.55-363.98
52wk Low-High 236.25-374.97
Volume 140,120
NAV (month end) NA

Zacks Premium Research for IBB

Zacks ETF Rank [?] Buy 2
ETF Risk [?] High
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.48%
Dividend (Yield) $0.45 (0.12%)
Issuer BLACKROCK

Benchmark for IBB

NASDAQ BIOTECHNOLOGY INDEX

The NASDAQ Biotechnology Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by the Funds Index Provider, NASDAQ OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Fund Summary for IBB

ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND

The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index